3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
37
Lymphoma, Follicular
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma
8
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell, Marginal Zone
4
Neoplasms
3
Smoldering Multiple Myeloma
2
Recurrence
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
HTLV-I Infections
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
trametinib
1
tazemetostat
1
palbociclib
1
olaparib
1
dabrafenib
1
Vemurafenib
1
Pharmacogenomic Variants
1
LY3023414
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
Lenalidomide
×
30 days
×
Clear all
No trials found.